Properties of pediatric aliquots of apheresis platelets stored in a polyolefin container

Related Experiment Video

Updated: May 14, 2026

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

Stephen J Wagner, Shalini Seetharaman, James Kurtz

    Transfusion
    |February 7, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
    12:40

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

    Published on: December 7, 2012

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
    10:32

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

    Published on: August 24, 2015

    Related Experiment Videos

    Last Updated: May 14, 2026

    Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
    05:57

    Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

    Published on: August 2, 2022

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
    12:40

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

    Published on: December 7, 2012

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
    10:32

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

    Published on: August 24, 2015

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

    Articles linked to this work by shared authors, journal, and citation graph.

    SAGES guidelines for the surgical treatment of hiatal hernias.

    Surgical endoscopy·2024

    Management of symptomatic, asymptomatic, and recurrent hiatal hernia: a systematic review and meta-analysis.

    Surgical endoscopy·2024

    Time from apheresis platelet donation to cold storage: Evaluation of platelet quality and bacterial growth.

    Transfusion·2022

    Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures.

    Blood transfusion = Trasfusione del sangue·2021

    Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction.

    Transfusion·2021

    Establishment of transfusion-relevant bacteria reference strains for red blood cells.

    Vox sanguinis·2020

    Long-term stability of human parvovirus B19 neutralizing antibody titer trends in donor-derived pooled plasma and plasma-derived immunoglobulin product lots in Japan.

    Transfusion·2026

    Shelf-life of cord blood red cell concentrates: Comparison of two additive solutions.

    Transfusion·2026

    Prophylactic oral calcium-vitamin D3-magnesium supplementation reduced citrate-related reactions during peripheral blood stem cell collection in healthy donors: A randomized controlled trial.

    Transfusion·2026

    Development of a systematic drug screening method for cord blood donation for transfusion to extremely preterm neonates.

    Transfusion·2026

    No transfusion-transmitted cytomegalovirus infections in neonates receiving leukoreduced-only blood products.

    Transfusion·2026

    Blocking FcγRI and FcγRIII reduces RBC phagocytosis induced by patient-derived anti-E and anti-K alloantibodies in vitro.

    Transfusion·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us